Holen Sie sich die Stockscreener-App
8.025
5.31%
-0.45
Handel nachbörslich:
8.11
0.085
+1.06%
Alvotech Aktie (ALVO) Neueste Nachrichten
Alvotech Reports Strong Growth and Strategic Expansion - TipRanks
Alvotech targets 50% U.S. Humira biosimilar market share by year-end as Q2 product revenues rise 77% - MSN
Alvotech (ALVO) Expected to Announce Earnings on Wednesday - MarketBeat
Alvotech Reports Strong H1 2025 Financials and Strategic Partnerships - MSN
Alvotech Reports Strong H1 2025 Financials and Strategic Partnerships. - AInvest
Alvotech's Q2 2025: Navigating Contradictions in Market Share, Revenue Guidance, and FDA Inspections - AInvest
Alvotech Plunges 9.5% Intraday: Can This Biosimilars Powerhouse Rebound From Debt-Driven Volatility? - AInvest
Transcript : Alvotech, H1 2025 Earnings Call, Aug 14, 2025 - MarketScreener
Alvotech shares fall 2.34% premarket despite reporting strong H1 2025 earnings and product revenue growth. - AInvest
Alvotech shares rise 2.68% premarket after reporting strong Q2 2025 results and 200% product revenue growth. - AInvest
Alvotech's Q1 Operating Income Surpassing $28.6M: A Catalyst for Long-Term Growth in a High-Potential Biosimilars Sector? - AInvest
Alvotech Posts $28.6M H1 Operating Income, Product Revenue Rises - AInvest
Alvotech H1 operating income USD 28.639 million - MarketScreener
Alvotech (ALVO) Is Up 5.9% After Swinging to Profit in H1 2025What's Changed - simplywall.st
Alvotech's Strategic Transformation and Financial Turnaround: A High-Conviction Buy Opportunity in Biosimilars - AInvest
Alvotech (ALVO) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Why Alvotech Shares Are Under Pressure - TipRanks
Alvotech earnings beat by $0.50, revenue topped estimates - Investing.com Nigeria
ALVOTECH Earnings Results: $ALVO Reports Quarterly Earnings - Quiver Quantitative
Alvotech soars as product revenue surges over 200% YoY By Investing.com - Investing.com Australia
Alvotech soars as product revenue surges over 200% YoY - Investing.com India
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update - Placera.se
Alvotech : Q2 2025Unaudited Condensed Consolidated Interim Financial Statements first 6 months - MarketScreener
Alvotech Reports Q2 Non-GAAP EPS of $0.49, Beating Estimates by $0.49, with Product Revenue Reaching $204.7 Million. - AInvest
Alvotech Reports Record Growth with 200% Increase in Product Revenues Year-on-Year and Best Quarter for Operating Cash Flows - Quiver Quantitative
Wall Street Analysts Think Alvotech (ALVO) Could Surge 102.31%: Read This Before Placing a Bet - sharewise.com
Why Alvotech stock attracts strong analyst attentionMarket Trend Summary & Fast Moving Market Watchlists - thegnnews.com
Alvotech to Report Q2 2025 Earnings on August 13, 2025, with Webcast on August 14, 2025 - AInvest
Alvotech's Q2 Earnings Preview: Analysts Expect $-0.11 EPS, Share Price Down 21.99% Over 52-Week Period - AInvest
Alvotech Rebounds From Oversold Zone — Now WhatAccurate Technical Trend Reversal Picks Detected - 선데이타임즈
Regression Model Predicts Rangebound Movement in AlvotechBuy Low Sell High Stock Watch Strategy in Focus - beatles.ru
MACD Signals Flash Warning for Alvotech StockLow Risk High Return Opportunities Identified - beatles.ru
Alvotech WRT ALVOW 2025Q2 Earnings Preview Upside Ahead on Revenue Growth Forecast - AInvest
What are Alvotech’s recent SEC filings showingAdvanced Entry Signal Stocks - thegnnews.com
Screener Results Flag Alvotech as OversoldCapital Preserving Trade Plan Templates Shared - metal.it
What makes Alvotech stock price move sharplyTop 100 Low Volatility Gainers - thegnnews.com
Who’s Hired? Rosemont Gains A Chairperson But Loses A CEO - insights.citeline.com
Earnings Preview: Alvotech to Report Financial Results Post-market on August 13 - 富途牛牛
Alvotech shares rise 1.89% after-hours following FDA approval of Ajovy for pediatric migraine prevention. - AInvest
Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 Am EDT - 富途牛牛
Alvotech to Release First Half 2025 Financial Results and Host Conference Call - Quiver Quantitative
Alvotech Reports Q2 2025 Earnings: Webcast and Conference Call Set for August 14 - AInvest
Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT - Yahoo Finance
Alvotech Reaches Critical Trendline SupportTechnical Signal Trend Tracker Prediction - beatles.ru
Can Alvotech Rally Enough to Break EvenAI Driven Buy Alert Trade Blueprint Released - metal.it
What analysts say about Alvotech stockRemarkably fast returns - Jammu Links News
What drives Alvotech Equity Warrant stock priceCapitalize on fast-growing stocks today - Jammu Links News
What is Alvotech Equity Warrant company’s growth strategyGain insights from top financial experts - Jammu Links News
What are Alvotech company’s key revenue driversCapitalize on emerging investment opportunities - Jammu Links News
Is Alvotech a good long term investmentAccelerated capital growth - Jammu Links News
What markets is Alvotech expanding into Is BuzzFeed Inc. stock a good long term investment option - Jammu Links News
What is the dividend policy of Alvotech Equity Warrant stockInvest smarter and grow your wealth faster - Jammu Links News
How volatile is Alvotech Equity Warrant stock compared to the marketCapitalize on fast-moving trading opportunities - Jammu Links News
How does Alvotech generate profit in a changing economyMaximize your portfolio’s earning potential - Jammu Links News
What are analysts’ price targets for Alvotech in the next 12 monthsTremendous portfolio expansion - Jammu Links News
Does Alvotech Equity Warrant stock perform well during market downturnsInvest smarter with actionable trading signals - Jammu Links News
What is the risk reward ratio of investing in Alvotech stockRapidly expanding wealth - Jammu Links News
What are Alvotech Equity Warrant company’s key revenue driversGet exclusive market analysis for investors - Jammu Links News
2.80%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):